Daniel Roses

Q: What Schools Are Affiliated With Daniel Roses

Daniel Roses is affiliated with the following schools: Stanford University, Johns Hopkins University, University of California, San Francisco, New York University, Harvard University

Daniel Roses's AcademicInfluence.com Rankings

Daniel Roses

Medical

#403

World Rank

#562

Historical Rank

#167

USA Rank

Surgery

#90

World Rank

#128

Historical Rank

#21

USA Rank

medical Degrees

Daniel Roses

Philosophy

#10861

World Rank

#14903

Historical Rank

#2028

USA Rank

Logic

#7709

World Rank

#9551

Historical Rank

#1197

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Daniel Roses's Degrees

Doctorate Medicine Harvard University
PhD Biomedical Engineering Stanford University

Why Is Daniel Roses Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Daniel F. Roses is an American surgeon who is the Jules Leonard Whitehill Professor of Surgery and Oncology of the New York University School of Medicine and a Senior Attending Surgeon at Tisch Hospital of the New York University Medical Center.

(See a Problem?)

Daniel Roses's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Sentinel-node biopsy or nodal observation in melanoma. (2006) (1348)
Prognostic signs and the role of operative management in acute pancreatitis. (1974) (1292)
Final trial report of sentinel-node biopsy versus nodal observation in melanoma. (2014) (1152)
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. (1999) (779)
Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial (2005) (589)
Objective early identification of severe acute pancreatitis. (1974) (307)
Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. (2004) (235)
The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I) (2010) (188)
Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. (1999) (180)
Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV Lesions (1982) (167)
Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. (2007) (164)
Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I) (2012) (163)
Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis (1982) (155)
Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals. (1996) (138)
“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness (1984) (134)
Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. (2012) (130)
Local and In‐Transit Metastases Following Definitive Excision for Primary Cutaneous Malignant Melanoma (1983) (115)
A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease (1981) (112)
Tissue Inhibitor of Metalloproteinases-2 Binding to Membrane-type 1 Matrix Metalloproteinase Induces MAPK Activation and Cell Growth by a Non-proteolytic Mechanism* (2008) (111)
Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine. (2001) (108)
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. (1982) (108)
Surgical treatment of dermatofibrosarcoma protuberans. (1986) (105)
Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma (2010) (94)
Prognosis of patients with pathologic stage II cutaneous malignant melanoma. (1985) (91)
Prone accelerated partial breast irradiation after breast-conserving surgery: five-year results of 100 patients. (2012) (87)
Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. (1982) (86)
Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. (2009) (85)
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. (1981) (82)
Early Respiratory Insufficiency in Acute Pancreatitis (1973) (81)
Respiratory complications in acute pancreatitis. (1974) (79)
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. (1981) (75)
Differentiation of radial scar from scirrhous carcinoma of the breast: mammographic-pathologic correlation. (1989) (74)
Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi. (1983) (71)
Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma. (2003) (70)
Perforated diverticula of the jejunum and lleum. (1976) (67)
Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine (1995) (64)
Prognostic index for malignant melanoma (1987) (61)
Survival with regional and distant metastases from cutaneous malignant melanoma. (1991) (60)
Immunogenicity of a polyvalent melanoma antigen vaccine in humans (1988) (56)
Prognostic index for malignant melanoma. (1978) (56)
Bacterial endocarditis associated with colorectal carcinoma. (1974) (50)
Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast. (1985) (50)
The Management of Pigmented Lesions of the Nail Bed (1996) (50)
Tubular carcinoma of the breast: sensitivity of diagnostic techniques and correlation with histopathology. (1999) (47)
Preparation and characterization of a polyvalent human melanoma antigen vaccine. (1986) (46)
Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma. (2003) (45)
Microinvasive Breast Cancer and the Role of Sentinel Node Biopsy: An Institutional Experience and Review of the Literature (2008) (44)
Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles. (1997) (44)
Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis. (1983) (44)
Poland's Syndrome and Carcinoma of the Breast: A Case Report (2001) (43)
Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation. (1991) (43)
Selective surgical management of cutaneous melanoma of the head and neck. (1980) (42)
Thoracotomy for metastatic malignant melanoma of the lung. (1990) (41)
Diagnosis and Management of Cutaneous Malignant Melanoma (1983) (40)
Malpractice litigation involving patients with carcinoma of the breast. (1995) (40)
Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node? (2006) (39)
Prone breast intensity modulated radiation therapy: 5-year results. (2014) (39)
Malignant melanoma. Primary surgical management (excision and node dissection) based on pathology and staging (1995) (37)
Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy. (2012) (37)
Aspiration biopsy and the clinical management of patients with malignant melanoma and palpable regional lymph nodes (2000) (35)
The use of preoperative localization of adenomas of the parathyroid glands by thallium-technetium subtraction scintigraphy, high-resolution ultrasonography and computed tomography. (1989) (35)
Assessment of Biopsy Techniques and Histopathologic Interpretations of Primary Cutaneous Malignant Melanoma (1979) (34)
Carcinoma of the thyroglossal duct (1983) (33)
Biopsy for microcalcification detected by mammography. (1980) (33)
Nipple‐sparing Mastectomy and Sub‐areolar Biopsy: To Freeze or not to Freeze? Evaluating the Role of Sub‐areolar Intraoperative Frozen Section (2016) (33)
Periorbital Melanocytic Lesions: Excision and Reconstruction in 40 Patients (1998) (30)
Lipid-rich follicular carcinoma of the thyroid in a patient with McCune-Albright syndrome. (1999) (29)
Invasive papillary carcinoma of the breast: mammographic appearance. (1990) (28)
Influence of anatomic location on prognosis of malignant melanoma: attempt to verify the BANS model. (1986) (28)
Poly(ADP-ribose) polymerase in human breast cancer: a case-control analysis. (1997) (28)
Limitations of Technetium 99m Sestamibi Scintigraphic Localization for Primary Hyperparathyroidism Associated with Multiglandular Disease (2003) (27)
Breast cancer malpractice litigation in New York State. (1993) (27)
A Cautionary Tale: Anaphylaxis to Isosulfan Blue Dye after 12 Years and 3339 Cases of Lymphatic Mapping (2008) (27)
Stereotaxic localization for fine-needle aspiration breast biopsy. Initial experience with 300 patients. (1991) (26)
Cutaneous melanoma of the breast. (1979) (25)
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation (2013) (24)
The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma (2017) (24)
Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine. (1991) (23)
Prediction of lymph node metastases from the histologic features of primary cutaneous malignant melanomas. (1984) (23)
Invasive carcinoma in clinically suspicious breast masses diagnosed as adenocarcinoma by fine‐needle aspiration (2000) (23)
Calcifications of the breast after reduction mammoplasty. (1990) (22)
Elastic fiber pattern in regressing melanoma: a histochemical and immunohistochemical study (2010) (21)
Elective radiation therapy for high-risk malignant melanomas. (2001) (20)
Febrile responses associated with cardiac surgery. Relationships to the postpericardiotomy syndrome and to altered host immunologic reactivity. (1974) (20)
Primary hyperparathyroidism associated with two enlarged parathyroid glands. (1989) (19)
Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed. (2016) (19)
Multiple Breast Cancer Cell-Lines Derived from a Single Tumor Differ in Their Molecular Characteristics and Tumorigenic Potential (2013) (18)
The carcinogenicity of radiation therapy. (1984) (18)
The diagnosis and management of common skin cancers (1981) (18)
Major vascular reconstruction for limb salvage in patients with soft tissue and skeletal sarcomas of the extremities. (1978) (17)
Circumscribed intraductal carcinoma of the breast. (1989) (17)
Melanoma of the Head and Neck (1975) (17)
Pregnancy‐associated breast cancer in a contemporary cohort of newly diagnosed women (2020) (17)
Mammographic detection of carcinoma of the breast in patients with augmentation prostheses. (1989) (16)
Lobular carcinoma of the male breast. (1994) (15)
Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection. (1991) (15)
Induction of tumor-infiltrating lymphocytes in human malignant melanoma metastases by immunization to melanoma antigen vaccine. (1989) (15)
Regional lymph node dissection for malignant melanoma of the extremities. (1981) (15)
Morphological and biological characteristics of mammogram-detected invasive breast cancer. (1996) (15)
Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS) (2019) (14)
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. (1982) (14)
Total Mastectomy with Complete Axillary Dissection (1981) (13)
Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions (2015) (13)
Axillary Dissection for Tubular Carcinoma of the Breast (1996) (13)
Computerized Axial Tomography in the Diagnosis and Management of Thyroid and Parathyroid Disorders (1984) (13)
Differentiation of postsurgical changes from carcinoma of the breast. (1988) (13)
Papillary thyroid carcinoma metastatic to skin may herald aggressive disease. (2010) (12)
Stereotactic aspiration biopsy of nonpalpable nodules of the breast. (1994) (12)
Mammographically detected breast lesions: clinical importance of cytologic atypia in stereotaxic fine-needle aspiration biopsy samples. (1996) (12)
Distinction between postsurgical changes and carcinoma by means of stereotaxic fine-needle aspiration biopsy after reduction mammaplasty. (1993) (11)
Surgical management for malignant melanoma of the trunk. (1981) (11)
Primary melanoma thickness correlated with regional lymph node metastases. (1982) (11)
The risk of carcinoma in wire localization biopsies for mammographically detected clustered microcalcifications. (1991) (11)
Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS) (2020) (11)
Recurrent breast cancer: stereotaxic localization for fine-needle aspiration biopsy. Work in progress. (1992) (10)
Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. (2008) (10)
Malignant melanoma. Delayed hypersensitivity skin testing. (1979) (10)
Tubular Carcinoma of the Breast: Immunohistochemical and DNA Flow Cytometric Profile (1999) (9)
Management considerations for melanonychia striata and melanoma of the hand. (1995) (9)
Irsogladine maleate inhibits angiogenesis in wild-type and plasminogen activator-deficient mice. (1998) (9)
Encapsulated Anaplastic Thyroid Carcinoma Transformed from Follicular Carcinoma (2009) (9)
A Nomogram to Predict Factors Associated with Lymph Node Metastasis in Ductal Carcinoma In Situ with Microinvasion (2019) (9)
Proper biopsy of a lesion suspect of being a malignant melanoma. (1982) (9)
Stereotactic Localization for Fine Needle Aspiration Biopsy in Patients with Augmentation Prostheses (1992) (9)
Numerical Abnormalities of Chromosomes 7, 18, and X in Precancerous Breast Disease Defined by Fluorescent In Situ Hybridization (1998) (9)
Total mastectomy with axillary dissection. A modified radical mastectomy. (1977) (9)
Fine Needle Aspiration Biopsy in Patients with Augmentation Prostheses and a Palpable Mass (1993) (8)
Higher Volume at Time of Breast Conserving Surgery Reduces Re-Excision in DCIS (2011) (8)
Stereotactic fine-needle aspiration biopsy for the evaluation of nonpalpable breast lesions: Report of an experience based on 2,988 cases (1996) (7)
Single-dose dacarbazine and dactinomycin in advanced malignant melanoma. (1985) (7)
Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma. (2011) (6)
A genomic ruler to assess oncogenic transition between breast tumor and stroma (2018) (5)
Thyroglossal duct carcinoma. (1974) (5)
Use of vaccines in treatment of malignant melanoma. (1996) (5)
Decrease in circulating tumor cells as an early marker of therapy effectiveness. (2001) (5)
Biopsy technique for suspected melanoma (1985) (4)
Surgery for primary cutaneous malignant melanoma. (1985) (4)
Primary melanoma thickness correlated with regional lymph node metastases (1983) (4)
A novel immunization strategy using cytokine/chemokines induces new effective systemic immune responses, and frequent complete regressions of human metastatic melanoma (2018) (3)
A Multivariate Analysis of Prognostic Factors for Melanoma Patients with Lesions > 3.65 mm in Thickness The Importance of Revealing Alternative Cox Models* (1982) (3)
Radial scar: cytologic evaluation by stereotactic aspiration (1994) (3)
From Hunter and the Great Pox to Jenner and smallpox. (1992) (3)
Prospective Randomized Trial of Prone Accelerated Intensity Modulated Whole-Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed: 3-Year Results (2014) (2)
Chapter 24 – Surgery for Breast Cancer (2005) (2)
Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ (2022) (2)
Novel Amyloid Precursor Protein Gene Late-Onset Alzheimer ’ s Disease Mutation ( Codon 665 ASP ) in a Patient with (2)
Localization of Nonpalpable Masses in Patients with Breast Implants (1993) (2)
On the sesquicentennial of Theodore Billroth. (1979) (2)
Randomized, double-blind, clinical trial of a polyvalent melanoma vaccine in patients with stage III melanoma (1998) (2)
Vaccine-induced CD 8 T-cell Responses to MAGE-3 Correlate with Clinical Outcome in Patients with Melanoma 1 (2003) (2)
Rapid Apolipoprotein E Associates with p3 Amyloid Peptide of Alzheimer's Disease to Form Novel Monofibrils Isoform ApoE4 Associates More Efficiently Than ApoE3 (2013) (2)
Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease (2019) (2)
Comparative Value of Mammography, Fine‐Needle Aspiration Biopsy, and Core Biopsy in the Diagnosis of Invasive Lobular Carcinoma (1998) (1)
Defining the definitive excision for primary cutaneous malignant melanoma. (1984) (1)
Abstract P2-01-02: The Incidence of Mammographically-Occult Breast Cancer in Women Older than Seventy Years (2010) (1)
Accelerated Breast Radiotherapy for Ductal Carcinoma In Situ (DCIS): Experience in 216 Trial Patients (2011) (1)
Brahms and Billroth. (1986) (1)
A Decade of Change: An Institutional Experience with Breast Surgery in 1995 and 2005 (2008) (1)
Chapter 21 – Development of Modern Breast Cancer Treatment (2005) (1)
Stereotaxic aspiration biopsy of the breast. (1993) (1)
Sarcoidosis of the breast. (1985) (1)
Association of low P27 with loss of hormone receptors in small (T1a/b) breast cancers. (2006) (1)
Stephen Smith. Pioneer of American surgery and public health. (1991) (1)
Malignant: Local and intransit metastases following definitive excision for primary cutaneous malignant melanoma (1984) (1)
Five-year results of preoperative concurrent paclitaxel with radiation in locally advanced breast cancer (LABC). (2010) (1)
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). (2022) (1)
Abstract P3-13-01: Determining the breast tumor margin through genomics of the cancer-stromal interaction (2017) (0)
Angiography as diagnostic aid in splenic trauma. (1974) (0)
Dr Mitnick and colleagues respond (1989) (0)
Stimulation of CD8+T cell responses to MAGE-3 and MART-1 by a shed, polyvalent melanoma antigen vaccine: 031 (1997) (0)
Clinically beneficial immune reponses to melanoma vaccine treatment: 104 (1993) (0)
Respiratory Complications in Acute Pancreatitis (1974) (0)
Abstract P2-08-27: Clinicopathologic characteristics of native vs. foreign-born breast cancer patients in a contemporary cohort (2020) (0)
STEREOTAXIC ASPIRATION BIOPSY OF THE BREAST. AUTHORS' REPLY (1993) (0)
Surgical Management of Hyperparathyroidism (2003) (0)
Clinical activity of a polyvalent melanoma vaccine (1993) (0)
White graft reaction after streptococcal and staphylococcal infection in man. (1973) (0)
Radar-guided vs. wire localization for non-palpable breast lesions. (2018) (0)
Mammographic Density and Lobular Involution in Older Women with Abnormal Breast Imaging. (2009) (0)
Loss of nuclear p27KIP1 (p27) expression as a predictor of lymph node spread in T1 breast cancer. (2012) (0)
Bilateral, Synchronous Breast Carcinoma in Monozygotic Male Twins with Multi‐system Developmental Anomalies: Proposition of a Congenital Etiology (2016) (0)
Vaccination's bicentennial: a surgical landmark. (1996) (0)
Analysis of Prone Accelerated Partial-Breast Irradiation After Breast-Conserving Surgery: 42 Month Follow-up Results of 200 Patients (2013) (0)
Diagnosis of metastatic melanoma to the breast by aspiration biopsy (1995) (0)
Mixed parathyroid-thymic cyst. (1981) (0)
Recruitment in the Internet era: An efficient strategy for a study of breast cancer risk. (2011) (0)
Abstract A038: The feasibility of inducing effective systemic immune responses to human metastatic melanoma with intralesional secreted cytokines (2016) (0)
Improved survival of melanoma patients with antibody responses to a polyvalent melanoma vaccine (1993) (0)
Use of artificial intelligence to analyze clinical database reduces workload on surgical house staff. (1994) (0)
Sucess of Brochure/One Page Universal Consent for Biospecimen Donation. (2009) (0)
Abstract P2-23-07: DNA Methylation Analysis of Triple Negative Breast Cancers (2023) (0)
Depletion of polymorphonuclear neutrophils (PMNS) inhibits angiogenesis in vivo (2000) (0)
Double-Blind Trial of a Polyvalent , Shed-Antigen , Melanoma Vaccine 1 (2001) (0)
Evolution of surgery for malignant melanoma. (1985) (0)
Head & Neck Endocrine Surgery (2021) (0)
The relationship of magnetic resonance (MR) imaging characteristics with race. (2015) (0)
Prognosis of patients with pathologic stage II cutaneous malignant melanoma (1986) (0)
Abstract P5-03-01: Not presented (2018) (0)
Lymphovascular Invasion Is Associated with Lymph Node Metastasis in Ductal Carcinoma in Situ with Microinvasion (2018) (0)
Bacterial Endocarditis Associated with Colored Carcinoma (1974) (0)
Reoperation for Primary Hyperparathyroidism (2003) (0)
Prone Partial-Breast Irradiation After Breast Conserving Surgery: Results of 397 Patients at a Median Follow-up of 40 Months (2015) (0)
IL-2 Liposomes markedly enhance the immunogenicity of a shed, polyvalent melanoma vaccine: 475 (1997) (0)
Abstract P5-04-09: Redefining the breast tumor margin through genomics of the tumor-stromal interaction (2013) (0)
Non-BRCA hereditary gene mutations and breast cancer phenotype: An ISC-RAM Consortia study. (2018) (0)

This paper list is powered by the following services:

Other Resources About Daniel Roses

en.wikipedia.org

What Schools Are Affiliated With Daniel Roses?

Daniel Roses is affiliated with the following schools:

Daniel Roses's Academic­Influence.com Rankings

Daniel Roses's Degrees

Why Is Daniel Roses Influential?

Daniel Roses's Published Works

Published Works

Other Resources About Daniel Roses

What Schools Are Affiliated With Daniel Roses?

Daniel Roses's AcademicInfluence.com Rankings